The University of Chicago Header Logo

Connection

Luciana Molinero to Doxorubicin

Back to Details
This is a "connection" page, showing publications Luciana Molinero has written about Doxorubicin.
Luciana Molinero
Connection Strength
0.042
Doxorubicin
  1. Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial. Lancet. 2020 10 10; 396(10257):1090-1100.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.